HK1050491A1 - Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor periopheries - Google Patents

Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor periopheries

Info

Publication number
HK1050491A1
HK1050491A1 HK03102709A HK03102709A HK1050491A1 HK 1050491 A1 HK1050491 A1 HK 1050491A1 HK 03102709 A HK03102709 A HK 03102709A HK 03102709 A HK03102709 A HK 03102709A HK 1050491 A1 HK1050491 A1 HK 1050491A1
Authority
HK
Hong Kong
Prior art keywords
periopheries
intraoperatively
angiogenesis
binding
order
Prior art date
Application number
HK03102709A
Other languages
English (en)
Inventor
Michael Schirner
Kai Licha
Ludger Dinkelborg
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7924318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1050491(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of HK1050491A1 publication Critical patent/HK1050491A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0039—Coumarin dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HK03102709A 1999-09-24 2003-04-15 Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor periopheries HK1050491A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947559A DE19947559A1 (de) 1999-09-24 1999-09-24 Antikörper-Farbstoffkonjugate gegen Zielstrukturen der Angiogenese zur intraoperativen Tumorranddarstellung
PCT/EP2000/008121 WO2001023005A1 (de) 1999-09-24 2000-08-19 Antikörper-farbstoffkonjugate gegen zielstrukturen der angiogenese zur intraoperativen tumorranddarstellung

Publications (1)

Publication Number Publication Date
HK1050491A1 true HK1050491A1 (en) 2003-06-27

Family

ID=7924318

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03102709A HK1050491A1 (en) 1999-09-24 2003-04-15 Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor periopheries

Country Status (23)

Country Link
EP (2) EP1532988A3 (ja)
JP (1) JP2003510294A (ja)
KR (2) KR20070087232A (ja)
CN (1) CN1269530C (ja)
AU (1) AU779026B2 (ja)
BG (1) BG65682B1 (ja)
BR (1) BR0014192A (ja)
CA (1) CA2385593A1 (ja)
CZ (1) CZ2002991A3 (ja)
DE (1) DE19947559A1 (ja)
EE (1) EE05176B1 (ja)
HK (1) HK1050491A1 (ja)
HU (1) HUP0202625A2 (ja)
IL (2) IL148405A0 (ja)
MX (1) MXPA02002639A (ja)
NO (1) NO20021441L (ja)
NZ (1) NZ517944A (ja)
RO (1) RO121598B1 (ja)
RU (1) RU2002109237A (ja)
SK (1) SK3972002A3 (ja)
WO (1) WO2001023005A1 (ja)
YU (1) YU20702A (ja)
ZA (1) ZA200203225B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4243201A (en) 2000-02-24 2001-09-03 Eidgenoess Tech Hochschule Antibody specific for the ed-b domain of fibronectin, conjugates comprising saidantibody, and their use for the detection and treatment of angiogenesis
US6440389B1 (en) * 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
AT413487B (de) 2002-08-12 2006-03-15 Igeneon Krebs Immuntherapie Verwendung von antikörpern gegen ein tumor-assoziiertes antigen
NO20034351D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av endometrose
EP1816475A1 (en) * 2004-07-22 2007-08-08 Bayer Schering Pharma Aktiengesellschaft Use of cyanine dyes for the diagnosis of disease associated with angiogenesis
EP1679082A1 (en) * 2005-01-07 2006-07-12 Schering AG Use of cyanine dyes for the diagnosis of proliferative diseases
US20120041305A1 (en) * 2009-04-21 2012-02-16 The University Of Utah Research Foundation Light-emitting dye for intraoperative imaging or sentinel lymph node biopsy
EP3493855A4 (en) * 2016-08-02 2020-04-01 ISI Life Sciences, Inc. METHOD FOR DETECTION OF CANCER CELLS.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341223A (en) * 1981-02-04 1982-07-27 Lutz Lauralee A Fluoresceable composition and method of determining fluid flow
CN1162184C (zh) * 1994-07-11 2004-08-18 德克萨斯州立大学董事会 用于脉管系统特异性凝血的组合物及其应用
TWI259837B (en) * 1998-05-11 2006-08-11 Eidgenossische Tech Hochscule Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis

Also Published As

Publication number Publication date
KR20070087232A (ko) 2007-08-27
IL148405A0 (en) 2002-09-12
NO20021441L (no) 2002-05-15
DE19947559A1 (de) 2001-04-19
AU6702600A (en) 2001-04-30
RU2002109237A (ru) 2003-11-27
CN1376074A (zh) 2002-10-23
KR20020039349A (ko) 2002-05-25
EP1532988A3 (de) 2008-09-17
SK3972002A3 (en) 2002-09-10
WO2001023005A1 (de) 2001-04-05
EE05176B1 (et) 2009-06-15
NZ517944A (en) 2004-06-25
BR0014192A (pt) 2002-05-21
BG65682B1 (bg) 2009-06-30
EP1214099A1 (de) 2002-06-19
BG106528A (bg) 2002-12-29
MXPA02002639A (es) 2002-07-30
EP1532988A2 (de) 2005-05-25
JP2003510294A (ja) 2003-03-18
YU20702A (sh) 2005-06-10
ZA200203225B (en) 2003-07-23
NO20021441D0 (no) 2002-03-22
CN1269530C (zh) 2006-08-16
CA2385593A1 (en) 2001-04-05
HUP0202625A2 (en) 2002-12-28
KR100832937B1 (ko) 2008-05-27
CZ2002991A3 (cs) 2002-06-12
RO121598B1 (ro) 2007-12-28
IL148405A (en) 2009-06-15
PL354027A1 (en) 2003-12-15
AU779026B2 (en) 2005-01-06
EE200200152A (et) 2003-04-15

Similar Documents

Publication Publication Date Title
AU3041100A (en) Binding of antibody fragments to solid supports
AU2605501A (en) Inducing cellular immune responses to prostate cancer antigens using peptide andnucleic acid compositions
EP1187633A4 (en) USE OF ANTI-VEGF ANTIBODY FOR INCREASING IRRADIATION IN CANCER THERAPY
EP1224274A4 (en) TUMORNESCROSE FACTOR RELATED RECEPTOR, TR6
AU2001253140A1 (en) Tumor markers in ovarian cancer
HUP0303749A3 (en) Renal cell carcinoma tumor markers
NO20011674D0 (no) Stropplös tålås-binding for snowboards
PL354508A1 (en) Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin
EP1147761A4 (en) LIPSTICK STICK COMPOSITION
HK1050491A1 (en) Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor periopheries
HUP0500180A2 (en) Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
EP1208232A4 (en) PROSTATE CANCER MARKERS
EG22346A (en) Process for the preparation of conjugates useful in the treatment of prostate cancer
EP1191940A4 (en) TUMORNESCROSE FACTOR RECEPTOR 5
NO20013607D0 (no) Skibinding for telemarkski
AU7099900A (en) Peptides that bind to urokinase receptor
GB2353306B (en) Improvements to ploughs
EP1210370A4 (en) TUMOR NECROSIS FACTOR TR16 HUMAN RECEPTOR
GB0018020D0 (en) Improvements to ploughs
GB2353305B (en) Improvements to ploughs
HK1039576A1 (zh) 作為癌症和前列腺疾病的治療劑的新的多元胺類似物綴合物和醌綴合物
TW431290U (en) Improved structure for joint connecting type hot runners of mold
NZ523207A (en) Antibodies that bind to tumor gene sequences
GB9921046D0 (en) Therapeutic antibody composition & use
GB2349322B (en) Improvements relating to heating elements

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100819